Trade Amgen AMGN

Sell
 Buy

Amgen live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Amgen News

Ava Grace 2025 Nov 08, 00:00

AI Funding Concerns Trigger Tech Stock Sell-Off

Sophia Claire 2025 Nov 08, 00:00

Gold Price Outlook: Currency Devaluation Trade Still Alive

Liam James 2025 Nov 08, 00:00

JPMorgan Sees Buying Opportunity Amid Market Jitters

Emma Rose 2025 Nov 07, 00:00

The Fed's Balance Sheet Expansion: Drivers and Potential Implications

Noah Lee 2025 Nov 07, 00:00

LME Aluminum Bull Run: Is a Structural Deficit Emerging?

Frances Wang 2025 Nov 06, 16:00

Gold and silver prices are up: what's happening to Gold (XAU/USD) and XAG?

Frances Wang 2025 Nov 06, 16:00

Nvidia Competitors Analysis (2026), NVDA Stock: AMD, Intel, Qualcomm, AVGO

Frances Wang 2025 Nov 05, 16:00

Crypto market update: Ethereum price drops, Bitcoin price falls below $104K

Frances Wang 2025 Nov 05, 16:00

XRP price prediction: XRP rebounds, Is XRP expected to go high?

Frances Wang 2025 Nov 05, 16:00

Tesla stock jumps 4% today: what’s driving the TSLA share price?

Latest news

Show more
Ava Grace 2025 Nov 10, 07:10

DeFi Protocol Losses: Risk Management Lessons and Mitigation Strategies

Sophia Claire 2025 Nov 10, 06:50

Daily Market Review & Trend Analysis: November 10th

Liam James 2025 Nov 10, 06:10

Long-Term Bitcoin Holders: Strategic Shifts to ETFs and Portfolio Diversification

Noah Lee 2025 Nov 10, 06:10

BlackRock's Tokenization Revolution: A Decentralization Illusion?

Noah Lee 2025 Nov 10, 04:40

Bitcoin Treasury Firms: Is the Downturn Nearing its End?

Noah Lee 2025 Nov 10, 04:10

James Chanos Closes MSTR & Bitcoin Short: A Shift in the Landscape?

Emma Rose 2025 Nov 10, 03:30

Trump Media's Q3 Loss Widens Despite Bitcoin Holdings

Liam James 2025 Nov 10, 03:10

Crypto Funding Weekly Recap: Nov 3-Nov 9 - Deals Top $800 Million

Info

Spread

2.12

Spread (%)

0.6641 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

172421513216

Shares Outstanding

538480671

Earnings Date (Next)

1999-11-22

Div Yield

2025-09-12

Ex-Dividend Date

2025-11-21

Forward annual dividend rate

9.52

Forward annual dividend yield

0.0297

EPS

12.94

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 06, 16:00

How to start cryptocurrency trading: how to trade BTC Price (BTC/USD) CFDs?

Ghko B 2025 Nov 06, 16:00

Xom Stock Forecast: What is the future forecast for XOM?

Ghko B 2025 Nov 06, 16:00

Top Australian Shares: Argo Investments, BHP, CBA stock and more

Trustpilot